GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Auro Laboratories Ltd (BOM:530233) » Definitions » Market Cap

Auro Laboratories (BOM:530233) Market Cap : ₹1,534.8 Mil (As of Apr. 10, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Auro Laboratories Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Auro Laboratories's share price for the quarter that ended in Dec. 2024 was ₹268.25. Auro Laboratories's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 6.2 Mil. Therefore, Auro Laboratories's market cap for the quarter that ended in Dec. 2024 was ₹1,672.0 Mil.

Auro Laboratories's quarterly market cap increased from Jun. 2024 (₹1,240.1 Mil) to Sep. 2024 (₹1,340.7 Mil) and increased from Sep. 2024 (₹1,340.7 Mil) to Dec. 2024 (₹1,672.0 Mil).

Auro Laboratories's annual market cap declined from Mar. 2022 (₹625.2 Mil) to Mar. 2023 (₹340.6 Mil) but then increased from Mar. 2023 (₹340.6 Mil) to Mar. 2024 (₹1,004.4 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Auro Laboratories's Enterprise Value for Today is ₹1,789.8 Mil.


Auro Laboratories Market Cap Historical Data

The historical data trend for Auro Laboratories's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Auro Laboratories Market Cap Chart

Auro Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 196.03 505.50 625.17 340.57 1,004.45

Auro Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 805.93 1,004.45 1,240.06 1,340.72 1,672.00

Competitive Comparison of Auro Laboratories's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Auro Laboratories's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Auro Laboratories's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Auro Laboratories's Market Cap distribution charts can be found below:

* The bar in red indicates where Auro Laboratories's Market Cap falls into.


;
;

Auro Laboratories Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Auro Laboratories's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as

Market Cap (A: Mar. 2024 )=Share Price (A: Mar. 2024 )*Shares Outstanding (EOP) (A: Mar. 2024 )
=₹161.15*6.233
=₹1,004.4

Auro Laboratories's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=₹268.25*6.233
=₹1,672.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Auro Laboratories  (BOM:530233) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Auro Laboratories Market Cap Related Terms

Thank you for viewing the detailed overview of Auro Laboratories's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Auro Laboratories Business Description

Traded in Other Exchanges
N/A
Address
S.K. Ahire Marg, 314, 3rd Floor, T.V. Industrial Estate, Worli, Mumbai, MH, IND, 400 030
Auro Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and selling of pharmaceutical products like Metformin Hydrochloride and Glibenclamide. The pharmaceutical products range offered by the company are anti-diabetic, muscle relaxant, diuretic, iron deficiency anti-fungal, anti-ulcer, iodine supplement, anti-malaria, antacids, anti-inflammatory, specialty chemicals, and others. The company sells its products in India and also exports it to international countries.

Auro Laboratories Headlines

No Headlines